Clinical Immunology Society Inc
- Assets
- $2.3m
- Revenue
- $1.5m
- Investments
- $0.0
- Employees
- 0
- Location
- Milwaukee, WI
- Founding
- 01/1987
- Data as of
- 12/2022
- EIN
- 52-1469030
Organization Overview
Clinical Immunology Society Inc is located in Milwaukee, WI. The organization was established in 1987. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Clinical Immunology Society Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Clinical Immunology Society Inc generated $1.5m in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 2.6% each year. All expenses for the organization totaled $1.2m during the year ending 12/2022. While expenses have increased by 4.3% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990T
Mission & Program ActivityExcerpts From the 990T Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
TO FACILITATE EDUCATION, TRANSLATIONAL RESEARCH AND NOVEL APPROACHES TO THERAPY IN CLINICAL IMMUNOLOGY TO PROMOTE EXCELLENCE IN THE CARE OF PATIENTS WITH IMMUNOLOGIC/INFLAMMATORY DISORDERS.
Describe the Organization's Program Activity:
ANNUAL MEETING: TO PROVIDE A STIMULATING AND LIVELY FORUM FOR PRESENTATION AND DISCUSSION OF THE LATEST ADVANCES IN CLINICAL IMMUNOLOGY, INCLUDING PRIMARY IMMUNODEFICIENCIES AND IMMUNE DYSREGULATORY DISEASES, AND RELATED AREAS, INCLUDING MOLECULAR PATHOGENESIS, AND NOVEL THERAPEUTIC APPROACHES.
PRIMARY IMMUNE DEFICIENCY SCHOOL: THE PRIMARY GOAL IS EDUCATION ON THE DIAGNOSIS, PATHOGENESIS, AND TREATMENT OF COMPLEX DISEASES. THE SECONDARY GOALS ARE TO ATTRACT AND DEVELOP FUTURE SCIENTISTS IN ACADEMIC MEDICINE AND TO ENHANCE THE AWARENESS OF CLINICAL IMMUNOLOGY AND ITS IMPORTANCE IN SCIENTIFIC DISCOVERIES AND CLINICAL APPLICATIONS. A THIRD GOAL IS TO STIMULATE FUTURE COLLABORATIONS BETWEEN YOUNG INVESTIGATORS AND EXPERIENCED PHYSICIAN/SCIENTISTS IN THE FIELD.
AIM SCHOOL: IN PARTNERSHIP WITH GRIFOLS, THIS EDUCATIONAL OFFERING FOR THE PIDD COMMUNITY WILL ADVANCE THE EARLY AND MORE ACCURATE DIAGNOSIS OF PIDDS; INFORM AND EDUCATE ABOUT THE INTERSECTION BETWEEN ACADEMIA, THE CLINIC AND INDUSTRY; AND MENTOR EARLY CAREER IMMUNOLOGISTS TO SUPPORT MOTIVATION AND ADVANCEMENT OF THE PRACTICE OF IMMUNOLOGY AND THE TREATMENT OF PIDDS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Sergio D Rosenzweig MD PHD President | OfficerTrustee | 5 | $0 |
Elie Haddad MD PHD President-Elect | OfficerTrustee | 5 | $0 |
Troy R Torgerson MD PHD Past President | OfficerTrustee | 5 | $0 |
Daniel C Adelman MD Secretary/treasurer | OfficerTrustee | 5 | $0 |
Megan A Cooper MD PHD Director | Trustee | 2 | $0 |
Jennifer Heimall MD Director | Trustee | 2 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $1,018,206 |
| Noncash contributions included in lines 1a–1f | $250 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $1,018,206 |
| Total Program Service Revenue | $456,282 |
| Investment income | $30,165 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $1,508,029 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $1,000 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $260,392 |
| Fees for services: Legal | $1,335 |
| Fees for services: Accounting | $7,000 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $15,605 |
| Fees for services: Other | $21,259 |
| Advertising and promotion | $5,912 |
| Office expenses | $52,173 |
| Information technology | $28,229 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $183,292 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $337,132 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $10,316 |
| Insurance | $2,145 |
| All other expenses | $17,940 |
| Total functional expenses | $1,207,893 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $392,817 |
| Savings and temporary cash investments | $11,564 |
| Pledges and grants receivable | $5,000 |
| Accounts receivable, net | $35,680 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $110,117 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $1,638,695 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $64,477 |
| Other assets | $0 |
| Total assets | $2,258,350 |
| Accounts payable and accrued expenses | $19,656 |
| Grants payable | $0 |
| Deferred revenue | $102,387 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $122,043 |
| Net assets without donor restrictions | $2,026,403 |
| Net assets with donor restrictions | $109,904 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $2,258,350 |
Grants Awarded
Over the last fiscal year, Clinical Immunology Society Inc has awarded $196,375 in support to 4 organizations.
| Grant Recipient | Amount |
|---|---|
BRIGHAM & WOMENS HOSP PURPOSE: PIDD Fellowship Award | $30,000 |
IMMUNE DEFICIENCY FOUNDATION PURPOSE: FILL PROJECT | $46,375 |
CHLDRNS HOSP OF PHILADEPHIA PURPOSE: PIDD Fellowship Award | $60,000 |
CHILDRENS HOSPITAL BOSTON PURPOSE: PIDD Fellowship Award | $60,000 |